April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Insulin-Like Growth Factor 2 (IGF2) is Reduced in Diabetic Retina and Serum
Author Affiliations & Notes
  • H. Imai
    Dept of Ophthalmology, PennState college of medicine, Hershey, Pennsylvania
  • M. K. Losiewicz
    Dept of Ophthalmology, PennState College of Medicine, Hershey, Pennsylvania
  • R. Goel
    Dept of Ophthalmology, PennState College of Medicine, Hershey, Pennsylvania
  • P. E. Fort
    Dept of Ophthalmology, PennState College of Medicine, Hershey, Pennsylvania
  • T. W. Gardner
    Dept of Ophthalmology, PennState College of Medicine, Hershey, Pennsylvania
  • Footnotes
    Commercial Relationships  H. Imai, None; M.K. Losiewicz, None; R. Goel, None; P.E. Fort, None; T.W. Gardner, None.
  • Footnotes
    Support  Juvenile Diabetes Research Foundation International
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 5093. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      H. Imai, M. K. Losiewicz, R. Goel, P. E. Fort, T. W. Gardner; Insulin-Like Growth Factor 2 (IGF2) is Reduced in Diabetic Retina and Serum. Invest. Ophthalmol. Vis. Sci. 2010;51(13):5093.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To examine the expression pattern of IGF2 isoforms in diabetic rat tissues and serum, and in serum of patients with Type 1 diabetees and retinopathy.

Methods: : For in vivo experiments, retinas and serum were extracted from streptozotocin induced 12 week diabetic male Sprague-Dawley rats and used for the western blot (WB) for IGF2. For ex vivo experiments, retinas were extracted from normal rats and incubated for 15min with or without mature-, big-, or pro-IGF2 (1-100nM). WB and immunoprecipitation were performed to assess the effect of each IGF2 isoform on insulin receptor (IR) and IGF1 receptor (IGF1R) autophosphorylation. For in vitro experiments, differentiated R28 cells were serum-deprived for 6 hours with or without treatment by recombinant IGF2 isoforms (1-100nM). WB, caspase-3 activity assay and DNA fragmentation ELISA were performed to check the anti-apoptotic effect of each IGF2 isoform.

Results: : In retina, big- and pro-IGF2 levels were reduced in diabetic rat and mature IGF2 was not detected in both normal and diabetic rat. In serum, all IGF2 isoforms were detected and were reduced in diabetic rat. IGF2 treatment significantly increased IR and IGF1R auto-phosphorylation in ex vivo retina and phosphorylation of GSK3beta, P70 6K, mTOR, MAPK and Akt dose-dependently (p<0.01) in vitro. IGF2 significantly decreased caspase-3 activity and DNA fragmentation induced by serum deprivation in vitro. Mature, big- and pro-IGF2 phosphorylated all pro-survival kinases (p<0.01) and decreased caspase-3 and DNA fragmentation.

Conclusions: : This data suggest that the reduced retinal and serum IGF2 levels may contribute to the development of neurodegeneration in diabetic retinopathy.

Keywords: diabetic retinopathy • neuroprotection • apoptosis/cell death 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×